Drug Type Therapeutic vaccine |
Synonyms Personalized neo-antigen peptides vaccine(Tianjin Hengjia Biotechnology Development), HJ-N-001 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePending |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Phase 1 | China | 24 Oct 2016 |
Pubmed | NEWS Manual | Phase 1 | EGFR-mutated non-small Cell Lung Cancer EGFR Mutation | - | uvhosyxvhf(nhjgsbcgko) = rwpzurenob rvelgzzbde (cveymrfgmm ) View more | Positive | 01 Sep 2021 |





